Latest News
MS treatments announcements from PBAC
The Pharmaceutical Benefits Advisory Committee (PBAC) makes recommendations to the Australian Government about the medicines for subsidy through the Pharmaceutical Benefits Scheme (PBS).
Today (21 August 2020), the Pharmaceutical Benefits Advisory Committee (PBAC) made the following...
Neurological Alliance Australia (NAA) Joint Position Statement regarding Expanded Telehealth
MS organisations to ‘speak with one voice’
The PM sends greetings to the MS Community ahead of World MS Day
MS Australia is thrilled to receive a video message from the Prime Minister, sending greetings to the Australian MS community ahead of World MS Day this Saturday 30 May.
Connecting this World MS Day!
With less than a week to go until World MS Day this Saturday 30 May, we wanted to share with you more about what we have planned, and how we can all connect with ourselves and each other!
When we looked at the new three-year World MS...
MS Australia partners with Women’s Health Week
MS Australia is pleased to announce a community partnership with Jean Hailes for Women’s Health for Women’s Health Week 2020.
The national health awareness campaign, held every September, raises awareness of the importance of maintaining good...
MS Australia Connections Hub launched today by Tim Ferguson
$1M funding commitment for MS research
Alcohol consumption during COVID-19 pandemic and MS brain health
Recently-released new data shows one in five Australians have bought more alcohol than usual during the COVID-19 pandemic, most people are drinking more and have concerns about their alcohol use and the drinking of others in their household.
National polling by...
MS treatments on July PBAC agenda
The MS Australia Board's statement in support of COVIDSafe App
MS treatments announcements from PBAC
The Pharmaceutical Benefits Advisory Committee (PBAC) makes recommendations to the Australian Government about the medicines for subsidy through the Pharmaceutical Benefits Scheme (PBS).
Today (24 April 2020), the Pharmaceutical Benefits Advisory Committee (PBAC) made the following...